Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease by Miguel Ángel Gómez-Sámano, Valerie Paola Vargas-Abonce, Froylan David Martínez-Sánchez, Lucía Palacios-Báez, Juan Mauricio Vera-Zertuche, María Fernanda Navarro-Flores, Mariana Guadalupe Morales-García, Jorge Ignacio Fonseca-Correa, Julia María Zuarth-Vázquez, Olynka Vega-Vega, Ricardo Correa-Rotter, Rodolfo Rincón-Pedrero, Luis E. Morales-Buenrostro, Josefina Alberú-Gómez, Julia Berenice Ramírez-González, Reyna Lizette Pacheco-Domínguez, Malaquías López-Cervantes, María de los Ángeles Mendoza-de-la-Garza, Yolanda Victoria Baeza-Arias, Ángeles Espinosa-Cuevas, Guadalupe López-Carrasco, Angelina López-Estrada, Luz Elizabeth Guillén-Pineda, Francisco Javier Gómez-Pérez, Daniel Cuevas-Ramos

Get full text